MAIA Biotechnology, Inc. (MAIA): Cash & Equivalents
$0
As of 2025-12-31
$0
As of 2026-06-30
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $0 | n/a | 2026-03-23, Balance as of period end |
| 2024-12-31 | $0 | n/a | 2026-03-23, Balance as of period end |
| 2023-12-31 | $0 | n/a | 2025-03-21, Balance as of period end |
| 2022-12-31 | $0 | n/a | 2024-03-21, Balance as of period end |
| 2021-12-31 | $0 | n/a | 2023-03-24, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | 2025-12-31 | $0 | n/a |
| Cocrystal Pharma, Inc. (COCP) | 2025-12-31 | $7.03M | -28.8% |
| FibroBiologics, Inc. (FBLG) | 2025-12-31 | $4.89M | -65.0% |
| Can-Fite BioPharma Ltd. (CANF) | 2025-12-31 | $5.53M | +14.6% |
| Kala Bio, Inc. (KALA) | 2025-12-31 | $7.56M | -85.2% |
| Korsana Biosciences, Inc. (KRSA) | 2025-12-31 | $3.24M | +0.2% |
| Medicus Pharma Ltd. (MDCX) | 2025-12-31 | $8.71M | +109.0% |
| Oragenics Inc (OGEN) | 2025-12-31 | $4.40M | +408.7% |
| Indaptus Therapeutics, Inc. (INDP) | 2025-12-31 | $8.51M | +47.0% |
Compare MAIA, COCP, FBLG, CANF side by side · Screen every company in Pharmaceutical Preparations ↗